Display options
Share it on

Methods Mol Biol. 2022;2303:477-486. doi: 10.1007/978-1-0716-1398-6_38.

Assays for Evaluation of Substrates for and Inhibitors of β-1,4-Galactosyltransferase 7.

Methods in molecular biology (Clifton, N.J.)

Emil Tykesson, Andrea Persson, Katrin Mani, Ulf Ellervik

Affiliations

  1. Department of Experimental Medical Science, Division of Neuroscience, Glycobiology Group, Lund University, Lund, Sweden.
  2. Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  3. Department of Experimental Medical Science, Division of Neuroscience, Glycobiology Group, Lund University, Lund, Sweden. [email protected].
  4. Department of Chemistry, Lund University, Lund, Sweden.

PMID: 34626402 DOI: 10.1007/978-1-0716-1398-6_38

Abstract

β-1,4-Galactosyltransferase 7 (β4GalT7) is a key enzyme in the synthesis of two classes of glycosaminoglycans (GAG), i.e., heparan sulfate (HS) and chondroitin/dermatan sulfate (CS/DS). GAG chains are linear polysaccharides of alternating hexuronic acid and N-acetylhexosamine residues, commonly linked to core proteins to form proteoglycans with important roles in the regulation of a range of biological processes. The biosynthesis of GAGs is initiated by xylosylation of a serine residue of the core protein followed by galactosylation, catalyzed by β4GalT7. The biosynthesis can also be initiated by xylosides carrying hydrophobic aglycons, such as 2-naphthyl β-D-xylopyranoside. We have cloned and expressed β4GalT7, and designed a cell-free assay to measure the activity of this enzyme. The assay employs a 96-well plate format for high throughput. In this chapter, we describe the cloning, expression, and purification of β4GalT7, as well as assays proposed for development of substrates for GAG priming and for investigating inhibitors of β4GalT7.

© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Keywords: Glycosaminoglycan biosynthesis; Inhibitor; Substrate; Xylosides; β-1,4-Galactosyltransferase 7

References

  1. Yip GW, Smollich M, Gotte M (2006) Therapeutic value of glycosaminoglycans in cancer. Mol Cancer Ther 5(9):2139–2148 - PubMed
  2. Afratis N, Gialeli C, Nikitovic D et al (2012) Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J 279(7):1177–1197 - PubMed
  3. Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U (2002) Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer 2(7):521–528 - PubMed
  4. Gotting C, Kuhn J, Zahn R et al (2000) Molecular cloning and expression of human UDP-d-xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J Mol Biol 304(4):517–528 - PubMed
  5. Almeida R, Levery SB, Mandel U et al (1999) Cloning and expression of a proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I. A seventh member of the human beta4-galactosyltransferase gene family. J Biol Chem 274(37):26165–26171 - PubMed
  6. Robinson HC, Brett MJ, Tralaggan PJ et al (1975) The effect of D-xylose, beta-D-xylosides and beta-D-galactosides on chondroitin sulphate biosynthesis in embryonic chicken cartilage. Biochem J 148(1):25–34 - PubMed
  7. Schwartz NB, Galligani L, Ho PL, Dorfman A (1974) Stimulation of synthesis of free chondroitin sulfate chains by beta-D-xylosides in cultured cells. Proc Natl Acad Sci U S A 71(10):4047–4051 - PubMed
  8. Tsutsui Y, Ramakrishnan B, Qasba PK (2013) Crystal structures of beta-1,4-galactosyltransferase 7 enzyme reveal conformational changes and substrate binding. J Biol Chem 288(44):31963–31970 - PubMed
  9. Krupicka M, Tvaroska I (2009) Hybrid quantum mechanical/molecular mechanical investigation of the beta-1,4-galactosyltransferase-I mechanism. J Phys Chem B 113(32):11314–11319 - PubMed
  10. Thorsheim K, Clementsona S, Tykesson E et al (2017) Hydroxylated oxanes as xyloside analogs for determination of the minimal binding requirements of β4GalT7. Tetrahedron Lett 58(35):3466–3469 - PubMed
  11. Siegbahn A, Manner S, Persson A et al (2014) Rules for priming and inhibition of glycosaminoglycan biosynthesis; probing the beta 4GalT7 active site. Chem Sci 5(9):3501–3508 - PubMed
  12. Siegbahn A, Aili U, Ochocinska A et al (2011) Synthesis, conformation and biology of naphthoxylosides. Bioorg Med Chem 19(13):4114–4126 - PubMed
  13. Siegbahn A, Thorsheim K, Ståhle J et al (2015) Exploration of the active site of beta 4GalT7: modifications of the aglycon of aromatic xylosides. Org Biomol Chem 13(11):3351–3362 - PubMed
  14. Studier FW (2005) Protein production by auto-induction in high density shaking cultures. Protein Expr Purif 41(1):207–234 - PubMed
  15. Ladner-Keay CL, Turner RJ, Edwards RA (2018) Fluorescent protein visualization immediately after gel electrophoresis using an in-gel trichloroethanol photoreaction with tryptophan. Methods Mol Biol 1853:179–190 - PubMed

Publication Types